We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.91B
AUM Growth
-$33.5M
Cap. Flow
-$96.8M
Cap. Flow %
-1.4%
Top 10 Hldgs %
55.6%
Holding
295
New
67
Increased
47
Reduced
98
Closed
74

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$81.6M
2
NVRO
NEVRO CORP.
NVRO
+$68M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$61.4M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$55.5M
5
KDP icon
Keurig Dr Pepper
KDP
+$44.2M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$105M
2
OGN icon
Organon & Co
OGN
+$75.3M
3
EXAS
Exact Sciences
EXAS
+$69M
4
BIIB icon
Biogen
BIIB
+$57.7M
5
CENTA icon
Central Garden & Pet Co Class A
CENTA
+$53.3M

Sector Composition

Rank Sector Weight
1 Healthcare 39.29%
2 Consumer Staples 5.94%
3 Technology 4.58%
4 Consumer Discretionary 4.41%
5 Communication Services 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NLSPW
201
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$53.5K ﹤0.01%
500,000
-1
-0% –
MOBBW
202
Mobilicom Ltd Warrants
MOBBW
$1.99B
$48.4K ﹤0.01%
242,100
-1
-0% –
BRSHW
203
DELISTED
Bruush Oral Care Inc. Warrant
BRSHW
$48.1K ﹤0.01%
600,962
-1
-0% –
ACONW icon
204
Aclarion Warrant
ACONW
$65.6K
$43.5K ﹤0.01%
550,000
-1
-0% –
FREEW
205
DELISTED
Whole Earth Brands, Inc. Warrant
FREEW
$42.3K ﹤0.01%
+211,300
New +$22.8K
SWAGW icon
206
Stran & Company Warrant
SWAGW
$37.6K ﹤0.01%
545,000
-1
-0% –
SVREW
207
SaverOne 2014 Ltd Warrant
SVREW
$48.9K
$36.3K ﹤0.01%
242,100
-1
-0% –
NXLIW
208
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$35.8K ﹤0.01%
325,000
-1
-0% –
GNLN icon
209
Greenlane Holdings
GNLN
$1.23M
$34.8K ﹤0.01%
+1
New +$188K
IVDAW icon
210
Iveda Solutions Warrant
IVDAW
$53.9K
$32.1K ﹤0.01%
145,000
-1
-0% –
BNCWW
211
CEA Industries Inc Warrant
BNCWW
$24.6K ﹤0.01%
700,000
-1
-0% –
AGRIW
212
DELISTED
AgriFORCE Growing Systems Ltd Warrant
AGRIW
$23.4K ﹤0.01%
600,000
-1
-0% –
KTTAW icon
213
Pasithea Therapeutics Warrants
KTTAW
$25.5K
$15.8K ﹤0.01%
1,000,000
-1
-0% –
AIMDW icon
214
Ainos Warrants
AIMDW
$7.17K ﹤0.01%
25,000
-1
-0% –
MDGSW
215
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$5.06K ﹤0.01%
85,714
-1
-0% –
SQLLW
216
DELISTED
SeqLL Inc. Warrant
SQLLW
$3.92K ﹤0.01%
50,000
-1
-0% –
TCBPW
217
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
$1.62K ﹤0.01%
37,647
-1
-0% –
AREBW
218
DELISTED
American Rebel Holdings Warrants
AREBW
$578 ﹤0.01%
193
-4,626
-96% -$13.1K
DRMAW icon
219
Dermata Therapeutics Warrant
DRMAW
$14.1K
$508 ﹤0.01%
20,313
-1
-0% –
EDBLW
220
Edible Garden AG Warrant
EDBLW
$128K
$501 ﹤0.01%
26,667
-1
-0% –
GMBLZ
221
DELISTED
Esports Entertainment Group Inc. Warrant
GMBLZ
$178 ﹤0.01%
27,000
-1
-0% –
AAP icon
222
Advance Auto Parts
AAP
$3.36B
– –
-4,296
Closed -$522K
ACI icon
223
Albertsons Companies
ACI
$5.58B
– –
-324,000
Closed -$6.73M
ALGT icon
224
Allegiant Air
ALGT
$2.78B
– –
-2,404
Closed -$221K
ASPI icon
225
ASP Isotopes
ASPI
$521M
– –
-3,164,557
Closed -$2.7M
7 8
9
10 11

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Armistice Capital held 295 positions worth $6.91B, down 0.48% from $6.94B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital's Q2 2023 filing shows 67 new, 47 increased, 98 reduced and 74 closed positions. Its largest new stake was Pfizer: 2,096,000 shares worth $76.9M. The largest sale was GSK, an estimated $105M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 44% a quarter earlier, followed by Consumer Staples and Technology.

  • Armistice Capital's largest Q2 2023 buy was Pfizer: 2,096,000 shares worth $76.9M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q2 2023, an estimated $55.5M increase.
  • Armistice Capital's biggest Q2 2023 reduction was GSK, cutting an estimated $105M.
  • Armistice Capital fully exited Organon & Co in Q2 2023, selling an estimated $75.3M.
  • Armistice Capital's ten largest holdings make up 56% of its $6.91B portfolio in Q2 2023.
  • Armistice Capital opened 67 new positions and closed 74 in Q2 2023.
  • Armistice Capital's portfolio value fell 0.48% quarter-over-quarter to $6.91B.

Based on Armistice Capital's 13F filing for Q2 2023, filed 14 Aug 2023.